-
1
-
-
78249252379
-
Kinin B1 receptor upregulation by angiotensin II and endothelin-1 in rat vascular smooth muscle cells: Receptors and mechanisms
-
Morand-Contant M, Anand-Srivastava MB, Couture R. Kinin B1 receptor upregulation by angiotensin II and endothelin-1 in rat vascular smooth muscle cells: receptors and mechanisms. Am J Physiol Heart Circ Physiol 2010; 299:H1625-H1632.
-
(2010)
Am J Physiol Heart Circ Physiol
, vol.299
-
-
Morand-Contant, M.1
Anand-Srivastava, M.B.2
Couture, R.3
-
2
-
-
77049085479
-
Differential regulation of inducible and endothelial nitric oxide synthase by kinin B1 and B2 receptors
-
Kuhr F, Lowry J, Zhang Y, et al. Differential regulation of inducible and endothelial nitric oxide synthase by kinin B1 and B2 receptors. Neuropeptides 2010; 44:145-154.
-
(2010)
Neuropeptides
, vol.44
, pp. 145-154
-
-
Kuhr, F.1
Lowry, J.2
Zhang, Y.3
-
3
-
-
67349177072
-
The kallikrein-kinin system in health and in diseases of the kidney
-
Kakoki M, Smithies O. The kallikrein-kinin system in health and in diseases of the kidney. Kidney Int 2009; 75:1019-1030.
-
(2009)
Kidney Int
, vol.75
, pp. 1019-1030
-
-
Kakoki, M.1
Smithies, O.2
-
4
-
-
0342829625
-
Bradykinin and cardiovascular system: Estimation of half-life
-
Saameli K, Eskes TK. Bradykinin and cardiovascular system: estimation of half-life. Am J Physiol 1962; 203:261-265.
-
(1962)
Am J Physiol
, vol.203
, pp. 261-265
-
-
Saameli, K.1
Eskes, T.K.2
-
5
-
-
0027175193
-
Differences in the properties and enzymatic specificities of the two active sites of angiotensin I-converting enzyme (kininase II). Studies with bradykinin and other natural peptides
-
Jaspard E, Wei L, Alhenc-Gelas F. Differences in the properties and enzymatic specificities of the two active sites of angiotensin I-converting enzyme (kininase II). Studies with bradykinin and other natural peptides. J Biol Chem 1993; 268:9496-9503. (Pubitemid 23146003)
-
(1993)
Journal of Biological Chemistry
, vol.268
, Issue.13
, pp. 9496-9503
-
-
Jaspard, E.1
Wei, L.2
Alhenc-Gelas, F.3
-
6
-
-
0033667449
-
Importance of quantitative genetic variations in the etiology of hypertension
-
Smithies O, Kim HS, Takahashi N, Edgell MH. Importance of quantitative genetic variations in the etiology of hypertension. Kidney Int 2000; 58:2265-2280.
-
(2000)
Kidney Int
, vol.58
, pp. 2265-2280
-
-
Smithies, O.1
Kim, H.S.2
Takahashi, N.3
Edgell, M.H.4
-
7
-
-
0031037629
-
Angiotensin-converting enzyme gene mutations, blood pressures, and cardiovascular homeostasis
-
Krege JH, Kim HS, Moyer JS, et al. Angiotensin-converting enzyme gene mutations, blood pressures, and cardiovascular homeostasis. Hypertension 1997; 29:150-157. (Pubitemid 27074036)
-
(1997)
Hypertension
, vol.29
, Issue.1
, pp. 150-157
-
-
Krege, J.H.1
Kim, H.-S.2
Moyer, J.S.3
Jennette, J.C.4
Peng, L.5
Hiller, S.K.6
Smithies, O.7
-
8
-
-
78649738484
-
Genetically determined angiotensin converting enzyme level and myocardial tolerance to ischemia
-
Messadi E, Vincent MP, Griol-Charhbili V, et al. Genetically determined angiotensin converting enzyme level and myocardial tolerance to ischemia. FASEB J 2010; 24:4691-4700.
-
(2010)
FASEB J
, vol.24
, pp. 4691-4700
-
-
Messadi, E.1
Vincent, M.P.2
Griol-Charhbili, V.3
-
9
-
-
0035818501
-
Genetically increased angiotensin I-converting enzyme level and renal complications in the diabetic mouse
-
DOI 10.1073/pnas.231476798
-
Huang W, Gallois Y, Bouby N, et al. Genetically increased angiotensin I-converting enzyme level and renal complications in the diabetic mouse. Proc Natl Acad Sci USA 2001; 98:13330-13334. (Pubitemid 33051362)
-
(2001)
Proceedings of the National Academy of Sciences of the United States of America
, vol.98
, Issue.23
, pp. 13330-13334
-
-
Huang, W.1
Gallois, Y.2
Bouby, N.3
Bruneval, P.4
Heudes, D.5
Belair, M.-F.6
Krege, J.H.7
Meneton, P.8
Marre, M.9
Smithies, O.10
Alhenc-Gelas, F.11
-
10
-
-
0025165779
-
An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels
-
Rigat B, Hubert C, Alhenc-Gelas F, et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86:1343-1346. (Pubitemid 20370444)
-
(1990)
Journal of Clinical Investigation
, vol.86
, Issue.4
, pp. 1343-1346
-
-
Rigat, B.1
Hubert, C.2
Alhenc-Gelas, F.3
Cambien, F.4
Corvol, P.5
Soubrier, F.6
-
11
-
-
77049087281
-
Plasma kallikrein and angiotensin I-converting enzyme N-and C-terminal domain activities are modulated by the insertion/deletion polymorphism
-
Almeida SS, Barros CC, Moraes MR, et al. Plasma kallikrein and angiotensin I-converting enzyme N-and C-terminal domain activities are modulated by the insertion/deletion polymorphism. Neuropeptides 2010; 44:139-143.
-
(2010)
Neuropeptides
, vol.44
, pp. 139-143
-
-
Almeida, S.S.1
Barros, C.C.2
Moraes, M.R.3
-
12
-
-
53749103611
-
Angiotensin converting enzyme insertion/deletion polymorphism and renoprotection in diabetic and nondiabetic nephropathies
-
Ruggenenti P, Bettinaglio P, Pinares F, Remuzzi G. Angiotensin converting enzyme insertion/deletion polymorphism and renoprotection in diabetic and nondiabetic nephropathies. Clin J Am Soc Nephrol 2008; 3:1511-1525.
-
(2008)
Clin J Am Soc Nephrol
, vol.3
, pp. 1511-1525
-
-
Ruggenenti, P.1
Bettinaglio, P.2
Pinares, F.3
Remuzzi, G.4
-
13
-
-
65649108517
-
Significance of genetic polymorphisms of the reninangiotensin-aldosterone system in cardiovascular and renal disease
-
Rudnicki M, Mayer G. Significance of genetic polymorphisms of the reninangiotensin-aldosterone system in cardiovascular and renal disease. Pharmacogenomics 2009; 10:463-476.
-
(2009)
Pharmacogenomics
, vol.10
, pp. 463-476
-
-
Rudnicki, M.1
Mayer, G.2
-
14
-
-
35448931632
-
Angiotensin-converting enzyme (ACE) inhibitors have different selectivity for bradykinin binding sites of human somatic ACE
-
DOI 10.1016/j.ejphar.2007.07.061, PII S0014299907008540
-
Ceconi C, Francolini G, Olivares A, et al. Angiotensin-converting enzyme (ACE) inhibitors have different selectivity for bradykinin binding sites of human somatic ACE. Eur J Pharmacol 2007; 577:1-6. (Pubitemid 47632513)
-
(2007)
European Journal of Pharmacology
, vol.577
, Issue.1-3
, pp. 1-6
-
-
Ceconi, C.1
Francolini, G.2
Olivares, A.3
Comini, L.4
Bachetti, T.5
Ferrari, R.6
-
15
-
-
74949129329
-
Angiotensin I-converting enzyme inhibitors are allosteric enhancers of kinin B1 and B2 receptor function
-
Erdös EG, Tan F, Skidgel RA. Angiotensin I-converting enzyme inhibitors are allosteric enhancers of kinin B1 and B2 receptor function. Hypertension 2010; 55:214-220.
-
(2010)
Hypertension
, vol.55
, pp. 214-220
-
-
Erdös, E.G.1
Tan, F.2
Skidgel, R.A.3
-
16
-
-
77956644609
-
The RAAS in the pathogenesis and treatment of diabetic nephropathy
-
Ruggenenti P, Cravedi P, Remuzzi G. The RAAS in the pathogenesis and treatment of diabetic nephropathy. Nat Rev Nephrol 2010; 6:319-330.
-
(2010)
Nat Rev Nephrol
, vol.6
, pp. 319-330
-
-
Ruggenenti, P.1
Cravedi, P.2
Remuzzi, G.3
-
17
-
-
0037446690
-
Vasopeptidase inhibitor omapatrilat induces profound insulin sensitization and increases myocardial glucose uptake in Zucker fatty rats: Studies comparing a vasopeptidase inhibitor, angiotensin-converting enzyme inhibitor, and angiotensin II type I receptor blocker
-
DOI 10.1161/01.CIR.0000062646.09566.CC
-
Wang CH, Leung N, Lapointe N, et al. Vasopeptidase inhibitor omapatrilat induces profound insulin sensitization and increases myocardial glucose uptake in Zucker fatty rats: studies comparing a vasopeptidase inhibitor, angiotensin-converting enzyme inhibitor, and angiotensin II type I receptor blocker. Circulation 2003; 107:1923-1929. (Pubitemid 36444136)
-
(2003)
Circulation
, vol.107
, Issue.14
, pp. 1923-1929
-
-
Wang, C.-H.1
Leung, N.2
Lapointe, N.3
Szeto, L.4
Uffelman, K.D.5
Giacca, A.6
Rouleau, J.L.7
Lewis, G.F.8
-
18
-
-
4644278885
-
Nephroprotection in Zucker diabetic fatty rats by vasopeptidase inhibition is partly bradykinin B2 receptor dependent
-
DOI 10.1038/sj.bjp.0705884
-
Schäfer S, Schmidts HL, Bleich M, et al. Nephroprotection in Zucker diabetic fatty rats by vasopeptidase inhibition is partly bradykinin B2 receptor dependent. Br J Pharmacol 2004; 143:27-32. (Pubitemid 39280021)
-
(2004)
British Journal of Pharmacology
, vol.143
, Issue.1
, pp. 27-32
-
-
Schafer, S.1
Schmidts, H.-L.2
Bleich, M.3
Busch, A.E.4
Linz, W.5
-
19
-
-
45149109175
-
Pharmacological blockade of B2-kinin receptor reduces renal protective effect of angiotensin-converting enzyme inhibition in db/db mice model
-
Buléon M, Allard J, Jaafar A, et al. Pharmacological blockade of B2-kinin receptor reduces renal protective effect of angiotensin-converting enzyme inhibition in db/db mice model. Am J Physiol Renal Physiol 2008; 294:F1249-F1256.
-
(2008)
Am J Physiol Renal Physiol
, vol.294
-
-
Buléon, M.1
Allard, J.2
Jaafar, A.3
-
20
-
-
77955373707
-
Cardioprotective properties of bradykinin: Role of the B(2) receptor
-
Manolis AJ, Marketou ME, Gavras I, Gavras H. Cardioprotective properties of bradykinin: role of the B(2) receptor. Hypertens Res 2010; 33:772-777.
-
(2010)
Hypertens Res
, vol.33
, pp. 772-777
-
-
Manolis, A.J.1
Marketou, M.E.2
Gavras, I.3
Gavras, H.4
-
21
-
-
0034619547
-
Myocardial protection by preconditioning of heart with losartan, an angiotensin II type 1-receptor blocker: Implication of bradykinin-dependent and bradykinin-independent mechanisms
-
Sato M, Engelman RM, Otani H, et al. Myocardial protection by preconditioning of heart with losartan, an angiotensin II type 1-receptor blocker: implication of bradykinin-dependent and bradykinin-independent mechanisms. Circulation 2000; 102:346-351.
-
(2000)
Circulation
, vol.102
, pp. 346-351
-
-
Sato, M.1
Engelman, R.M.2
Otani, H.3
-
22
-
-
79951674873
-
The angiotensin II type 1 receptor antagonist losartan binds and activates bradykinin B2 receptor signaling
-
Bonde MM, Olsen KB, Erikstrup N, et al. The angiotensin II type 1 receptor antagonist losartan binds and activates bradykinin B2 receptor signaling. Regul Pept 2011; 167:21-25.
-
(2011)
Regul Pept
, vol.167
, pp. 21-25
-
-
Bonde, M.M.1
Olsen, K.B.2
Erikstrup, N.3
-
23
-
-
33646408788
-
Senescence-associated phenotypes in Akita diabetic mice are enhanced by absence of bradykinin B2 receptors
-
Kakoki M, Kizer CM, Yi X, et al. Senescence-associated phenotypes in Akita diabetic mice are enhanced by absence of bradykinin B2 receptors. J Clin Invest 2006; 116:1302-1309.
-
(2006)
J Clin Invest
, vol.116
, pp. 1302-1309
-
-
Kakoki, M.1
Kizer, C.M.2
Yi, X.3
-
24
-
-
35348837283
-
2-kinin receptors protects against the development of diabetic nephropathy
-
DOI 10.1152/ajprenal.00203.2007
-
Tan Y, Keum JS, Wang B, et al. Targeted deletion of B2-kinin receptors protects against the development of diabetic nephropathy. Am J Physiol Renal Physiol 2007; 293:F1026-F1035. (Pubitemid 47583934)
-
(2007)
American Journal of Physiology - Renal Physiology
, vol.293
, Issue.4
-
-
Tan, Y.1
Keum, J.-S.2
Wang, B.3
McHenry, M.B.4
Lipsitz, S.R.5
Jaffa, A.A.6
-
25
-
-
20144367334
-
1 kinin receptor in the regulation of cardiac function and remodeling after myocardial infarction
-
DOI 10.1161/01.HYP.0000153322.04859.81
-
Xu J, Carretero OA, Sun Y, et al. Role of the B1 kinin receptor in the regulation of cardiac function and remodeling after myocardial infarction. Hypertension 2005; 45:747-753. (Pubitemid 40418376)
-
(2005)
Hypertension
, vol.45
, Issue.SUPPL.
, pp. 747-753
-
-
Xu, J.1
Carretero, O.A.2
Sun, Y.3
Shesely, E.G.4
Rhaleb, N.-E.5
Liu, Y.-H.6
Liao, T.-D.7
Yang, J.J.8
Bader, M.9
Yang, X.-P.10
-
26
-
-
66649088302
-
Gene deletion of the kinin receptor B1 attenuates cardiac inflammation and fibrosis during the development of experimental diabetic cardiomyopathy
-
Westermann D, Walther T, Savvatis K, et al. Gene deletion of the kinin receptor B1 attenuates cardiac inflammation and fibrosis during the development of experimental diabetic cardiomyopathy. Diabetes 2009; 58:1373-1381.
-
(2009)
Diabetes
, vol.58
, pp. 1373-1381
-
-
Westermann, D.1
Walther, T.2
Savvatis, K.3
-
27
-
-
58249110409
-
Delayed blockade of the kinin B1 receptor reduces renal inflammation and fibrosis in obstructive nephropathy
-
Klein J, Gonzalez J, Duchene J, et al. Delayed blockade of the kinin B1 receptor reduces renal inflammation and fibrosis in obstructive nephropathy. FASEB J 2009; 23:134-142.
-
(2009)
FASEB J
, vol.23
, pp. 134-142
-
-
Klein, J.1
Gonzalez, J.2
Duchene, J.3
-
28
-
-
79956019655
-
Bradykinin receptor 1 activation exacerbates experimental focal and segmental glomerulosclerosis
-
Pereira RL, Buscariollo BN, Correa-Costa M, et al. Bradykinin receptor 1 activation exacerbates experimental focal and segmental glomerulosclerosis. Kidney Int 2011; 79:1217-1227.
-
(2011)
Kidney Int
, vol.79
, pp. 1217-1227
-
-
Pereira, R.L.1
Buscariollo, B.N.2
Correa-Costa, M.3
-
29
-
-
34250654947
-
Bradykinin B1 and B2 receptors both have protective roles in renal ischemia/reperfusion injury
-
DOI 10.1073/pnas.0701617104
-
Kakoki M, McGarrah RW, Kim HS, Smithies O. Bradykinin B1 and B2 receptors both have protective roles in renal ischemia/reperfusion injury. Proc Natl Acad Sci USA 2007; 104:7576-7581. (Pubitemid 47185948)
-
(2007)
Proceedings of the National Academy of Sciences of the United States of America
, vol.104
, Issue.18
, pp. 7576-7581
-
-
Kakoki, M.1
McGarrah, R.W.2
Kim, H.-S.3
Smithies, O.4
-
30
-
-
77953471168
-
Lack of both bradykinin B1 and B2 receptors enhances nephropathy, neuropathy, and bone mineral loss in Akita diabetic mice
-
Kakoki M, Sullivan KA, Backus C, et al. Lack of both bradykinin B1 and B2 receptors enhances nephropathy, neuropathy, and bone mineral loss in Akita diabetic mice. Proc Natl Acad Sci USA 2010; 107:10190-10195.
-
(2010)
Proc Natl Acad Sci USA
, vol.107
, pp. 10190-10195
-
-
Kakoki, M.1
Sullivan, K.A.2
Backus, C.3
-
31
-
-
34249821061
-
Mice deficient for both kinin receptors are normotensive and protected from endotoxin-induced hypotension
-
DOI 10.1096/fj.06-7175com
-
Cayla C, Todiras M, Iliescu R, et al. Mice deficient for both kinin receptors are normotensive and protected from endotoxin-induced hypotension. FASEB J 2007; 21:1689-1698. (Pubitemid 46855614)
-
(2007)
FASEB Journal
, vol.21
, Issue.8
, pp. 1689-1698
-
-
Cayla, C.1
Todiras, M.2
Iliescu, R.3
Saul, V.V.4
Gross, V.5
Pilz, B.6
Chai, G.7
Merino, V.F.8
Pesquero, J.B.9
Baltatu, O.C.10
Bader, M.11
-
32
-
-
77954930286
-
Loss of bradykinin signaling does not accelerate the development of cardiac dysfunction in type 1 diabetic Akita mice
-
Wende AR, Soto J, Olsen CD, et al. Loss of bradykinin signaling does not accelerate the development of cardiac dysfunction in type 1 diabetic Akita mice. Endocrinology 2010; 151:3536-3542.
-
(2010)
Endocrinology
, vol.151
, pp. 3536-3542
-
-
Wende, A.R.1
Soto, J.2
Olsen, C.D.3
-
33
-
-
0141426735
-
Variation in bradykinin receptor genes increases the cardiovascular risk associated with hypertension
-
DOI 10.1016/S0195-668X(03)00441-X
-
Dhamrait SS, Payne JR, Li P, et al. Variation in bradykinin receptor genes increases the cardiovascular risk associated with hypertension. Eur Heart J 2003; 24:1672-1680. (Pubitemid 37174908)
-
(2003)
European Heart Journal
, vol.24
, Issue.18
, pp. 1672-1680
-
-
Dhamrait, S.S.1
Payne, J.R.2
Li, P.3
Jones, A.4
Toor, I.S.5
Cooper, J.A.6
Hawe, E.7
Palmen, J.M.8
Wootton, P.T.E.9
Miller, G.J.10
Humphries, S.E.11
Montgomerya, H.E.12
-
34
-
-
0036011343
-
1
-
DOI 10.1139/y02-036
-
Maltais I, Bachvarova M, Maheux P, et al. Bradykinin B2 receptor gene polymorphism is associated with altered urinary albumin/creatinine values in diabetic patients. Can J Physiol Pharmacol 2002; 80:323-327. (Pubitemid 34451248)
-
(2002)
Canadian Journal of Physiology and Pharmacology
, vol.80
, Issue.4
, pp. 323-327
-
-
Maltais, I.1
Bachvarova, M.2
Maheux, P.3
Perron, P.4
Marceau, F.5
Bachvarov, D.6
-
35
-
-
43049163718
-
Free radicals and senescence
-
Lu T, Finkel T. Free radicals and senescence. Exp Cell Res 2008; 314:1918-1922.
-
(2008)
Exp Cell Res
, vol.314
, pp. 1918-1922
-
-
Lu, T.1
Finkel, T.2
-
36
-
-
77958535818
-
Kinin B1 receptor enhances the oxidative stress in a rat model of insulin resistance: Outcome in hypertension, allodynia and metabolic complications
-
Dias JP, Talbot S, Séné cal J, et al. Kinin B1 receptor enhances the oxidative stress in a rat model of insulin resistance: outcome in hypertension, allodynia and metabolic complications. PLoS One 2010; 5:e12622.
-
(2010)
PLoS One
, vol.5
-
-
Dias, J.P.1
Talbot, S.2
Sénécal, J.3
-
37
-
-
0035134432
-
The effect of bradykinin on the oxidative state of rats with acute hyperglycaemia
-
DOI 10.1016/S0168-8227(00)00222-9, PII S0168822700002229
-
Mikrut K, Paluszak J, Kozlik J, et al. The effect of bradykinin on the oxidative state of rats with acute hyperglycemia. Diabetes Res Clin Pract 2001; 51:79-85. (Pubitemid 32140860)
-
(2001)
Diabetes Research and Clinical Practice
, vol.51
, Issue.2
, pp. 79-85
-
-
Mikrut, K.1
Paluszak, J.2
Kozlik, J.3
Sosnowski, P.4
Krauss, H.5
Grzeskowiak, E.6
-
38
-
-
33748959733
-
Nitric oxide and the respiratory enzyme
-
DOI 10.1016/j.bbabio.2006.05.011, PII S0005272806001332, Mitochondria: from Molecular Insight to Physiology and Pathology
-
Brunori M, Forte E, Arese M, et al. Nitric oxide and the respiratory enzyme. Biochim Biophys Acta 2006; 1757:1144-1154. (Pubitemid 44442121)
-
(2006)
Biochimica et Biophysica Acta - Bioenergetics
, vol.1757
, Issue.9-10
, pp. 1144-1154
-
-
Brunori, M.1
Forte, E.2
Arese, M.3
Mastronicola, D.4
Giuffre, A.5
Sarti, P.6
-
39
-
-
79951864902
-
A novel pathway for receptormediated posttranslational activation of inducible nitric oxide synthase
-
Brovkovych V, Zhang Y, Brovkovych S, et al. A novel pathway for receptormediated posttranslational activation of inducible nitric oxide synthase. J Cell Mol Med 2011; 15:258-269.
-
(2011)
J Cell Mol Med
, vol.15
, pp. 258-269
-
-
Brovkovych, V.1
Zhang, Y.2
Brovkovych, S.3
-
40
-
-
0038362736
-
2 receptor
-
Schanstra JP, Duchene J, Praddaude F, et al. Decreased renal NO excretion and reduced glomerular tuft area in mice lacking the bradykinin B2 receptor. Am J Physiol Heart Circ Physiol 2003; 284:H1904-H1908. (Pubitemid 36622398)
-
(2003)
American Journal of Physiology - Heart and Circulatory Physiology
, vol.284
-
-
Schanstra, J.P.1
Duchene, J.2
Praddaude, F.3
Bruneval, P.4
Tack, I.5
Chevalier, J.6
Girolami, J.-P.7
Bascands, J.-L.8
-
41
-
-
79952143828
-
A modest decrease in endothelial NOS in mice comparable to that associated with human NOS3 variants exacerbates diabetic nephropathy
-
Wang CH, Li F, Hiller S, et al. A modest decrease in endothelial NOS in mice comparable to that associated with human NOS3 variants exacerbates diabetic nephropathy. Proc Natl Acad Sci USA 2011; 108:2070-2075.
-
(2011)
Proc Natl Acad Sci USA
, vol.108
, pp. 2070-2075
-
-
Wang, C.H.1
Li, F.2
Hiller, S.3
-
42
-
-
59849109480
-
Bradykinin protects against oxidative stress-induced endothelial cell senescence
-
Oeseburg H, Iusuf D, van der Harst P, et al. Bradykinin protects against oxidative stress-induced endothelial cell senescence. Hypertension 2009; 53:417-422.
-
(2009)
Hypertension
, vol.53
, pp. 417-422
-
-
Oeseburg, H.1
Iusuf, D.2
Van Der Harst, P.3
-
43
-
-
39349102362
-
Prostacyclin protects renal tubular cells from gentamicin-induced apoptosis via a PPARalpha-dependent pathway
-
Hsu YH, Chen CH, Hou CC, et al. Prostacyclin protects renal tubular cells from gentamicin-induced apoptosis via a PPARalpha-dependent pathway. Kidney Int 2008; 73:578-587.
-
(2008)
Kidney Int
, vol.73
, pp. 578-587
-
-
Hsu, Y.H.1
Chen, C.H.2
Hou, C.C.3
-
44
-
-
0031081639
-
Effects of cicaprost and fosinopril on the progression of rat diabetic nephropathy
-
DOI 10.1016/S0895-7061(96)00319-6, PII S0895706196003196
-
Villa E, Rabano A, Ruilope LM, et al. Effects of cicaprost and fosinopril on the progression of rat diabetic nephropathy. Am J Hypertens 1997; 10:202-208. (Pubitemid 27084632)
-
(1997)
American Journal of Hypertension
, vol.10
, Issue.2
, pp. 202-208
-
-
Villa, E.1
Rabano, A.2
Ruilope, L.M.3
Garcia-Robles, R.4
|